• No results found

University of Groningen Towards improved and broadly protective influenza vaccines Bhide, Yoshita

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Towards improved and broadly protective influenza vaccines Bhide, Yoshita"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Towards improved and broadly protective influenza vaccines

Bhide, Yoshita

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Bhide, Y. (2018). Towards improved and broadly protective influenza vaccines: Focus on delivery systems,

routes of administration and animal models. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions Yoshita Chandravadan Bhide

“Towards improved and broadly protective

influenza vaccines”

1. Vaccination is the foundation for the control of influenza, therefore it is very important to educate people to get vaccinated.

2. Influenza pandemics can be devastating as testified by the Spanish Flu (1918) which kil-led 50-100 million people corresponding to 3-5% of the world’s population at that time. An influenza vaccine which can provide protection against a broad range of influenza viruses and can thereby mitigate future influenza pandemics is therefore urgently nee-ded.

3. Vaccination with whole inactivated virus influenza vaccines combined with mucosal adjuvants is a promising approach for achieving protection (This thesis).

4. Pre-existing immunity could be harnessed for making an influenza vaccine broadly pro-tective, as most of the population has been exposed to influenza at least once (This thesis).

5. Studies pinpointing immune mechanisms of protection are necessary. They can guide the future development of influenza vaccine (This thesis).

6. Protection against influenza is a complex process which involves more than one immune parameter to be optimally effective (This thesis).

7. Cotton rats could be used as an animal model for influenza vaccine evaluation; however several parameters like age of the animals, virus strain used, and infection dose need to be chosen carefully (This thesis).

8. I have not failed. I’ve just found 10,000 ways that won’t work (Thomas A. Edison). 9. The highest education is that which does not merely give us information but makes our

Referenties

GERELATEERDE DOCUMENTEN

Because aIIV3 has been introduced so recently in the US market (our study comparing HD-IIV3 with aIIV3 was during the first two season that aIIV3 was available), more seasons need

Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients.. Impact of The Daily Plan on Length of Stay

An economic assessment of high-dose influenza vaccine: Estimating the vaccine- preventable burden of disease in the United States using real-world data.. University

The research described in my thesis was performed at the Department of Medical Microbiology of the University Medical Center Groningen (UMCG) within the Groningen University

Current or seasonal trivalent influenza vaccines (TIVs) comprise of either inactivated or live attenuated antigens of influenza strains (H1N1, H3N2 and influenza B strain) that

In order to determine the relative efficacy of WIV vaccines combined with different adjuvants, mice were vaccinated three times via the most suitable route of administration with

To explore the immune mechanisms involved in protection from weight loss and lung virus growth upon challenge, antibody responses induced by sequential infection with PR8 and X-31

Mice were vaccinated twice as described above with modified NC99 (H1N1)-derived virosomes with admixed or attached HK68 NP, with HK68 NP + MPLA or with plain virosomes and